Literature DB >> 19547971

Commentary on: Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients.

Isabelle Brenot-Rossi1, Cyrille Bastide.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19547971     DOI: 10.1007/s00259-009-1191-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure.

Authors:  Isabelle Brenot-Rossi; Dominique Rossi; Benjamin Esterni; Serge Brunelle; Guillaume Chuto; Cyrille Bastide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-09       Impact factor: 9.236

2.  Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications.

Authors:  M S Cookson; N E Fleshner; S M Soloway; W R Fair
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

3.  Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.

Authors:  Karim Touijer; Farhang Rabbani; Javier Romero Otero; Fernando P Secin; James A Eastham; Peter T Scardino; Bertrand Guillonneau
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

4.  Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases.

Authors:  C Bastide; I Brenot-Rossi; S Garcia; D Rossi
Journal:  Eur J Surg Oncol       Date:  2008-06-06       Impact factor: 4.424

5.  Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients.

Authors:  G Holl; R Dorn; H Wengenmair; D Weckermann; J Sciuk
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-09       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.